14 Mar 2018

United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of...

Download pdf

07 Mar 2018

United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United...

Download pdf

21 Feb 2018

United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31...

Download pdf

15 Feb 2018

United Therapeutics Announces Settlement Of Patent Litigation With Actavis Laboratories FL, Inc. Relating To Orenitram

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Actavis Laboratories...

Download pdf

14 Feb 2018

United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 Financial Results Before The Market Opens On Wednesday, February 21, 2018

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results...

Download pdf

03 Jan 2018

Corsair Pharma and United Therapeutics Enter into Strategic Collaboration to Advance Novel Treprostinil Prodrugs

SOUTH SAN FRANCISCO, Calif. and SILVER SPRING, Md., Jan. 3, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR), a leading biotechnology company focused on development of therapies for the treatment of...

Download pdf

28 Dec 2017

United Therapeutics Corporation To Present At 36th Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of...

Download pdf

20 Nov 2017

United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca®

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric...

Download pdf

25 Oct 2017

United Therapeutics Corporation Reports Third Quarter 2017 Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2017."Our...

Download pdf

23 Oct 2017

United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new...

Download pdf

19 Oct 2017

United Therapeutics Corporation To Report Third Quarter 2017 Financial Results Before The Market Opens On Wednesday, October 25, 2017

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2017 financial results before the...

Download pdf

19 Sep 2017

Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2017 /PRNewswire/ -- Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes...

Download pdf